District Court, E.D. Pennsylvania, 2026

In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability...

In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability...
District Court, E.D. Pennsylvania · Decided February 3, 2026
In re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability...

Trial Court Opinion

UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION IN RE: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION MDL No. 3094 (SEE ATTACHED SCHEDULE) CONDITIONAL TRANSFER ORDER (CTO -51) On February 2, 2024, the Panel transferred 17 civil action(s) to the United States District Court for the Eastern District of Pennsylvania for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. See 717 F.Supp.3d 1370 (J.P.M.L. 2024). Since that time, 145 additional action(s) have been transferred to the Eastern District of Pennsylvania. With the consent of that court, all such actions have been assigned to the Honorable Karen S. Marston.

It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Eastern District of Pennsylvania and assigned to Judge Marston.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the Eastern District of Pennsylvania for the reasons stated in the order of February 2, 2024, and, with the consent of that court, assigned to the Honorable Karen S. Marston.

This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Eastern District of Pennsylvania. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel. seiigapsim me | cathe com IN MUCTIDISTRICT LITIGATION La a a, : Marcella R. Lockert Atti js Acting Clerk of the Panel Deputy Clerk, U.S.:District Court eee Pe it ena IN RE: GLUCAGON−LIKE PEPTIDE−1 RECEPTOR AGONISTS (GLP−1 RAS) PRODUCTS LIABILITY LITIGATION MDL No. 3094 SCHEDULE CTO−51 − TAG−ALONG ACTIONS DIST DIV. C.A.NO. CASE CAPTION CALIFORNIA NORTHERN CAN 3 26−00467 Pringles v. Novo Nordisk Inc et al NEW JERSEY NJ 2 26−00553 WEBB v. NOVO NORDISK A/S et al NJ 2 26−00558 BOWMAN v. NOVO NORDISK A/S et al NJ 2 26−00645 PETERS v. NOVO NORDISK A/S et al NJ 2 26−00646 MAYBERRY v. NOVO NORDISK A/S et al NJ 2 26−00647 YOUNG v. NOVO NORDISK A/S et al NJ 2 26−00648 LEWIS v. NOVO NORDISK A/S et al

Case-law data current through December 31, 2025. Source: CourtListener bulk data.